EUVIMEDEUVIMED entdecken
Crossref

Co-Encapsulation of Indocyanine Green J-Aggregate and Paclitaxel in Biodegradable Polymersomes for Photoacoustic-Guided Chemotherapy

Mohammed R Kawelah iD, Ceren Atila Dincer, Ananthakrishnan Soundaram Jeevarathinam iD, Sangheon Han iD, Samuel John, Joel Brisola, Jayasurya Dileep, Advaith A Kamath, Michael Chen, Richard Bouchard, Alexander E Marras iD, Thomas M Truskett iD und 2 weitere

ACS Applied Bio Materials · 2026

DOI: 10.1021/acsabm.6c00107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Mohammed R Kawelah und 13 weiteren Autor:innen. Beteiligte Einrichtung: McKetta Department of Chemical Engineering, The University of Texas, Austin, Texas78712, United States. Hauptthemen laut MEDLINE: Paclitaxel, Indocyanine Green, Photoacoustic Techniques, Biocompatible Materials. Die Arbeit nennt 68 Literaturangaben. Gefördert von: NIBIB NIH HHS, Welch Foundation, Cancer Prevention and Research Institute of Texas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of solid tumors remains one of the biggest challenges in oncology. Targeted nanotherapeutics could significantly improve treatment efficacy and reduce side effects. However, their efficient implementation requires knowledge of pharmacokinetics (PK) and biodistribution (BD) during therapy administration that would allow dose optimization for personalized treatment. To address this need, we developed a nanotheranostic platform that combines photoacoustic imaging (PAI) with near-infrared contrast agents (i.e., indocyanine green J-aggregates, ICGJ) and anticancer drugs (i.e., paclitaxel, PTX) co-encapsulated in biodegradable and pH-sensitive sub-100 nm polymersomes (PTX-ICGJ-Ps) that are composed of all FDA-approved materials. The thick hydrophobic membrane of ICGJ-Ps not only provides protection of the imaging agent, ICGJ, but also facilitates high loading of PTX (10% w/w), and pH-dependent sustained release of the drug. PTX-ICGJ-Ps targeted to human epidermal growth factor receptors (PTX-ICGJ-Ps-aEGFR) exhibit a prolonged and target-specific cytotoxic effect on triple-negative breast cancer (TNBC) cells after just 30 min of treatment, which is significantly higher than the treatment with the free drug. Furthermore, the interaction of PTX-ICGJ-Ps-aEGFR with TNBC cells can be monitored by PAI with high specificity and sensitivity. These data indicate that PTX-ICGJ-Ps-aEGFR meet many of the key attributes of a clinically translatable platform for development of image-guided, personalized therapy of TNBC and other tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelIndocyanine GreenPhotoacoustic TechniquesBiocompatible MaterialsAntineoplastic AgentsAntineoplastic Agents, PhytogenicPolymersHumansMaterials TestingDrug Screening Assays, AntitumorParticle SizeAnimalsCell SurvivalMolecular Structure

Stichwörter der Autor:innen

J-aggregatesPA-guided drug deliverydrug deliveryimage-guided drug deliveryindocyanine greenpaclitaxelphotoacoustic imagingpolymersomes

Substanzen

PaclitaxelIndocyanine GreenBiocompatible MaterialsAntineoplastic AgentsAntineoplastic Agents, PhytogenicPolymers

Autor:innen und Institutionen

  • McKetta Department of Chemical Engineering, The University of Texas, Austin, Texas78712, United States.
  • Department of Chemical Engineering, Faculty of Engineering, Ankara University, Ankara06100, Turkey.
  • Department of Imaging Physics, MD Anderson Cancer Center, Houston, Texas77030, United States.
  • Department of Bioengineering, Rice University, Houston, Texas77005, United States.
  • Walker Department of Mechanical Engineering, The University of Texas, Austin, Texas78712, United States.
  • Texas Materials Institute, The University of Texas, Austin, Texas78712, United States.

ORCID-Profile: Mohammed R Kawelah, Ananthakrishnan Soundaram Jeevarathinam, Sangheon Han, Alexander E Marras, Thomas M Truskett, Konstantin V Sokolov, Keith P Johnston

Förderung

  • NIBIB NIH HHS
  • Welch Foundation
  • Cancer Prevention and Research Institute of Texas
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institutes of Health (NIH)

Zitieren

APA

Kawelah, M. R., Atila Dincer, C., Jeevarathinam, A. S., Han, S., John, S., Brisola, J., Dileep, J., Kamath, A. A., Chen, M., Bouchard, R., Marras, A. E., Truskett, T. M., Sokolov, K. V., & Johnston, K. P. (2026). Co-Encapsulation of Indocyanine Green J-Aggregate and Paclitaxel in Biodegradable Polymersomes for Photoacoustic-Guided Chemotherapy. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00107

Vancouver

Kawelah MR, Atila Dincer C, Jeevarathinam AS, Han S, John S, Brisola J, et al. Co-Encapsulation of Indocyanine Green J-Aggregate and Paclitaxel in Biodegradable Polymersomes for Photoacoustic-Guided Chemotherapy. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00107

BibTeX
@article{Kawelah2026,
  author = {Kawelah, Mohammed R and Atila Dincer, Ceren and Jeevarathinam, Ananthakrishnan Soundaram and Han, Sangheon and John, Samuel and Brisola, Joel and Dileep, Jayasurya and Kamath, Advaith A and Chen, Michael and Bouchard, Richard and Marras, Alexander E and Truskett, Thomas M and Sokolov, Konstantin V and Johnston, Keith P},
  title = {Co-Encapsulation of Indocyanine Green J-Aggregate and Paclitaxel in Biodegradable Polymersomes for Photoacoustic-Guided Chemotherapy},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c00107}
}
Kostenlos starten →